Georgian medical news · 2025
INNOVATIVE APPROACHES TO THE DIAGNOSIS AND TREATMENT OF HYPERTENSION: USE OF TECHNOLOGY AND PROSPECTS.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Serediuk L, Dekhtiar Y, Barabanchyk O, Hruzevskyi O, Sosnov M
Аннотация
INTRODUCTION: Research in hypertension management highlights a significant gap in the effectiveness, accessibility, and patient-centricity of existing approaches. This study aims to examine the effectiveness of digital health, telemedicine, wearable devices, and hybrid approaches in hypertension management, addressing short-term and long-term outcomes and identifying implementation challenges.
METHODS: This study retrieved data from studies indexed in the Scopus, WoS, PubMed, and IEEE Xplore databases, "published between 2020 and 2025." The search keywords included "hypertension diagnosis," "therapy technologies," namely "artificial intelligence" (AI), "telemedicine," and "wearables." Bias assessments followed the Cochrane Collaboration, STROBE, and NOS with high inter-observer reliability.
RESULTS: This study included studies spanning multiple countries and revealed that digital health interventions, such as remote monitoring of blood pressure and artificial intelligence-supported apps, show significant short-term blood pressure reductions and improved patient adherence. Telemedicine and wearable technologies demonstrated positive outcomes in blood pressure control and patient engagement. Hybrid approaches, including artificial intelligence-driven decision support, exhibited promising potential but had limited impact on visit attendance. Long-term effects were mixed, with digital health solutions like the iHEC-APP showing early signs of sustained blood pressure improvements but requiring further evaluation.
CONCLUSION: Hypertension interventions show promise, but long-term efficacy, scalability, gender-sensitive approaches, and patient engagement remain key challenges, necessitating further research and development.
METHODS: This study retrieved data from studies indexed in the Scopus, WoS, PubMed, and IEEE Xplore databases, "published between 2020 and 2025." The search keywords included "hypertension diagnosis," "therapy technologies," namely "artificial intelligence" (AI), "telemedicine," and "wearables." Bias assessments followed the Cochrane Collaboration, STROBE, and NOS with high inter-observer reliability.
RESULTS: This study included studies spanning multiple countries and revealed that digital health interventions, such as remote monitoring of blood pressure and artificial intelligence-supported apps, show significant short-term blood pressure reductions and improved patient adherence. Telemedicine and wearable technologies demonstrated positive outcomes in blood pressure control and patient engagement. Hybrid approaches, including artificial intelligence-driven decision support, exhibited promising potential but had limited impact on visit attendance. Long-term effects were mixed, with digital health solutions like the iHEC-APP showing early signs of sustained blood pressure improvements but requiring further evaluation.
CONCLUSION: Hypertension interventions show promise, but long-term efficacy, scalability, gender-sensitive approaches, and patient engagement remain key challenges, necessitating further research and development.